Viewing Study NCT07348393


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 7:31 AM
Study NCT ID: NCT07348393
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-16
First Post: 2025-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module